Care Gaps in Sodium-Glucose Cotransporter-2 Inhibitor and Renin Angiotensin System Inhibitor Prescriptions for Patients with Diabetic Kidney Disease

被引：0
|
作者：
Sharon Rikin
Stephanie Deccy
Chenshu Zhang
Jill Crandall
Yuting Deng
Ladan Golestaneh
机构：
[1] Montefiore Medical Center and Albert Einstein College of Medicine,Division of General Internal Medicine
[2] Montefiore Medical Center and Albert Einstein College of Medicine,undefined
来源：
Journal of General Internal Medicine | 2023年 / 38卷
关键词：
chronic kidney disease; evidence-based medicine; diabetes mellitus; sodium-glucose cotransporter-2 inhibitor; renin and angiotensin system inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1599 / 1605
页数：6
相关论文
共 50 条
  • [31] Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
    Arow, M.
    Waldman, M.
    Yadin, D.
    Nudelman, V.
    Shainberg, A.
    Abraham, N. G.
    Freimark, D.
    Kornowski, R.
    Aravot, D.
    Hochhauser, E.
    Arad, M.
    CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
  • [32] THERAPEUTIC EFFECTS OF A SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR IN DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE
    Hirao, Jun
    Onoda, Shou
    Murayama, Yoshiki
    Uematsu, Mayu
    Ishimitsu, Akira
    Kaiga, Akiko
    Satonaka, Hiroshi
    Ishimitsu, Toshihiko
    JOURNAL OF HYPERTENSION, 2021, 39 : E212 - E212
  • [33] Sodium-glucose cotransporter 2 inhibitor effects on cardiovascular outcomes in chronic kidney disease
    Shivakumar, Oshini
    Sattar, Naveed
    Wheeler, David C.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 43 - 47
  • [34] Effectiveness and Safety of Sodium-Glucose Cotransporter-2 Inhibitor Continuation in Patients With Type 2 Diabetes and Late-Stage Chronic Kidney Disease
    Denny, Olivia
    Albanese, Nicole P.
    Meaney, Calvin J.
    Siwarski, Nicole E.
    Monte, Scott V.
    JOURNAL OF PHARMACY TECHNOLOGY, 2025, 41 (02) : 65 - 71
  • [35] Dietary Changes Leading to Euglycemic Diabetic Ketoacidosis in Sodium-Glucose Cotransporter-2 Inhibitor Users: A Challenge for Primary Care Physicians?
    Somagutta, Manoj Kumar Reddy
    Uday, Utkarsha
    Shama, Nishat
    Bathula, Narayana Reddy
    Pendyala, Siva
    Mahadevaiah, Ashwini
    Mahmutaj, Greta
    Ngardig, Ngaba Negumadji
    KOREAN JOURNAL OF FAMILY MEDICINE, 2022, 43 (06): : 361 - 366
  • [36] Impact of Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) Use in Kidney Transplant Recipients
    Arnaldi, M.
    Alzaneen, G. K.
    House, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S606 - S607
  • [37] SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR (SGLT2I) USE IN PATIENTS WITH FONTAN CIRCULATION
    Brenzel, Thomas
    Gaydos, Stephanie
    McHugh, Kimberly E.
    Woodard, Frances Kline
    Savage, Andrew
    Gregg, David
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1653 - 1653
  • [38] Competing Effects of Renin Angiotensin System Blockade and Sodium-Glucose Cotransporter-2 Inhibitors on Erythropoietin Secretion in Diabetes
    Marathias, Katerina P.
    Lambadiari, Vaia A.
    Markakis, Konstantinos P.
    Vlahakos, Vassilios D.
    Bacharaki, Dimitra
    Raptis, Athanasios E.
    Dimitriadis, George D.
    Vlahakos, Demetrios V.
    AMERICAN JOURNAL OF NEPHROLOGY, 2020, 51 (05) : 349 - 356
  • [39] Euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter-2 inhibitor use: a case report and review of the literature
    Diaz-Ramos, Alexis
    Eilbert, Wesley
    Marquez, Diego
    INTERNATIONAL JOURNAL OF EMERGENCY MEDICINE, 2019, 12 (01)
  • [40] Effects of Sodium-Glucose Cotransporter 2 Inhibitor on Carnitine Metabolism in Type 2 Diabetic Patients
    Harada, Marina
    Higa, Mariko
    Ohira, Akeo
    Kanaguchi, Momoko
    Miyashita, Naoko
    Doi, Ayano
    Yamashita, Kaoru
    Ouchi, Hiromi
    Ichijo, Takamasa
    DIABETES, 2016, 65 : A287 - A287
12345